Recent genomic clustering analyses revealed that p53/Rb and Wnt/β-catenin are the leading pathways altered in the ACC molecular subgroup with the poorest outcome [9–11], suggesting that these pathways together play a significant role in the tumorigenesis of ACC. The gene discussed is TP53; the disease is adrenal cortex carcinoma.